Finance

Lists
Why is 2315 down 2,85%?
Dive Deeper
2315:HKG
Biocytogen Phrmutcls (Beijing) Co Ltd
HK$49,16
-2,85%
(-1,44) 1D
16 Okt., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2315...
Open
HK$53,85
High
HK$53,85
Low
HK$48,30
Mkt. cap
40,06 mjd
Avg. vol.
1,84 m
Volume
2,00 m
P/E ratio
49,16
52-wk high
HK$80,65
52-wk low
HK$21,54
EPS
HK$1,00
No. of employees
2 k
Open
HK$53,85
High
HK$53,85
Low
HK$48,30
Mkt. cap
40,06 mjd
Avg. vol.
1,84 m
Volume
2,00 m
P/E ratio
49,16
52-wk high
HK$80,65
52-wk low
HK$21,54
EPS
HK$1,00
No. of employees
2 k
News stories
From web sources and news partners
About Biocytogen Phrmutcls (Beijing) Co Ltd
CEO-
Employees1,92 k
Founded2008
Headquarters-
Sector-
Websitebiocytogen.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
319,92 m
437,93 m
433,06 m
508,33 m
Cost of goods sold
108,15 m
102,19 m
91,46 m
61,86 m
Cost of revenue
108,15 m
102,19 m
91,46 m
61,86 m
Research and development expenses
103,94 m
125,00 m
117,69 m
149,65 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61,26 m
125,71 m
84,91 m
124,30 m
Operating expense
177,20 m
260,43 m
207,66 m
266,43 m
Total operating expenses
285,34 m
362,61 m
299,13 m
328,30 m
Operating income
34,57 m
75,31 m
133,93 m
180,04 m
Other non operating income
-1,05 m
-23,84 k
-8,66 m
8,66 m
EBT including unusual items
69,46 m
58,95 m
105,29 m
143,28 m
EBT excluding unusual items
10,96 m
71,36 m
109,36 m
137,63 m
Income tax expense
3,33 m
-121,11 k
1,26 m
6,22 m
Effective tax rate
4,80%
-0,21%
1,19%
4,34%
Other operating expenses
7,76 m
2,44 m
1,46 m
-3,91 m
Net income
66,13 m
59,07 m
104,03 m
137,06 m
Net profit margin
20,67%
13,49%
24,02%
26,96%
Earnings per share
-
-
-
-
Interest and investment income
806,98 k
1,10 m
1,04 m
1,55 m
Interest expense
-18,52 m
-16,55 m
-16,95 m
-19,06 m
Net interest expenses
-17,72 m
-15,45 m
-15,91 m
-17,51 m
Depreciation and amortization charges
-
-
-
-
EBITDA
62,08 m
97,41 m
160,09 m
220,87 m
Gain or loss from assets sale
-794,31 k
-208,67 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme